Abstract

Background Short stature (SS) is a common growth disorder with multiple aetiologies. Variants in the MMP13 gene can result in varying degrees of SS, typically accompanied by pronounced skeletal abnormalities. This study aimed to investigate the genetic basis of SS in a family lacking significant imaging abnormalities and elucidate the underlying pathogenic mechanism. Methods Trio whole-exome sequencing was performed in a Chinese pedigree with SS to identify pathogenic variants, followed by Sanger sequencing validation. Patient-derived induced pluripotent stem cell model and CRISPR/Cas9-generated Mmp13 R459fs homologous mutant mouse model were established to verify the pathogenicity of the variant. Western blotting, immunofluorescence staining, co-immunoprecipitation coupled with mass spectrometry (Co-IP/MS), histological staining and transmission electron microscopy were used to evaluate the effects of the variant on MMP13 protein function and chondrocyte development. Results A heterozygous frameshift variant, NM_002427.4:c.1372del(p.Arg458Valfs*31), was identified in the MMP13 gene. Mmp13 R459fs mutant mice recapitulated the SS phenotype in patients, with growth plate abnormalities that were present only during the growth phase and resolved earlier than those in Mmp13 knockout mice. Co-IP/MS in HEK293T cells revealed significantly increased HSPA5 expression in the mutant, and enhanced interaction between MMP13 mutant and HSPA5 was confirmed, leading to their retention within the endoplasmic reticulum (ER). In patient-derived chondrocytes, misfolded MMP13 protein upregulated HSPA5 expression, induced significant ER dilation, activated unfolded protein response and increased chondrocyte apoptosis, ultimately contributing to MMP13 -related SS. Conclusion This study for the first time reports the MMP13 c.1372del (p.Arg458Valfs*31) variant causes autosomal dominant SS without obvious skeletal abnormalities. The variant is associated with defective MMP13 protein secreti